...
机译:经导管主动脉瓣膜置换伴侣(主动脉转基管阀的放置)试验和登记后的预测因子和临床结果
Columbia Univ Med Ctr New York NY 10032 USA;
Columbia Univ Med Ctr New York NY 10032 USA;
Columbia Univ Med Ctr New York NY 10032 USA;
Cardiovasc Res Fdn New York NY USA;
Emory Univ Sch Med Atlanta GA USA;
Duke Clin Res Inst Durham NC USA;
Emory Univ Sch Med Atlanta GA USA;
Hosp Univ Penn Philadelphia PA 19104 USA;
Baylor Healthcare Syst Plano TX USA;
Cedars Sinai Med Ctr Los Angeles CA 90048 USA;
Stanford Univ Sch Med Stanford CA 94305 USA;
Medstar Washington Hosp Ctr Washington DC USA;
Cleveland Clin Cleveland OH 44106 USA;
Hosp Univ Penn Philadelphia PA 19104 USA;
St Pauls Hosp Vancouver BC V6Z 1Y6 Canada;
Columbia Univ Med Ctr New York NY 10032 USA;
Columbia Univ Med Ctr New York NY 10032 USA;
Columbia Univ Med Ctr New York NY 10032 USA;
Columbia Univ Med Ctr New York NY 10032 USA;
Columbia Univ Med Ctr New York NY 10032 USA;
cardiac conduction; pacemaker; PARTNER; TAVR; transcatheter aortic valve replacement;
机译:经导管主动脉瓣置换术后永久性起搏器植入的预测因素和临床结果PARTNER(AoRtic TraNscathetER瓣膜放置)试验和注册
机译:经股动脉导管主动脉瓣置换术后的结果比较随机的PARTNER(置入动脉穿刺导管的瓣膜)试验与NRCA(非随机连续入路)注册的比较
机译:经PARTNER(主动脉导管置入)试验的结果可预测经导管主动脉瓣置换后预后不良
机译:无需患者数据共享的中心间交叉验证和微调,可预测经导管主动脉瓣植入的结果
机译:SAPIEN 3经截觉管主动脉瓣膜置换后新的永久起搏器植入的解剖预测因子
机译:严重主动脉瓣狭窄患者中经导管主动脉瓣置换后B型钠尿肽升高与2年死亡率相关:多中心前瞻性OCEAN-TAVI(经导管最佳瓣膜介入治疗-经导管主动脉瓣植入)注册的见解
机译:经导管主动脉瓣置换术后永久性起搏器植入的预测因素和临床结果PARTNER(AoRtic TraNscathetER瓣膜放置)试验和注册